Exome Asset Management
Andrew Tom is an experienced finance professional currently serving as an Investor at Exome Asset Management since March 2025. Prior to this role, Andrew held the positions of Chief Financial Officer and Advisor at OXMAN from August 2021 to January 2025, and served as an Investor at Millennium from June 2019 to December 2021. Andrew's career includes significant roles at Citadel, Goldwater Asset Management, and J.P. Morgan, as well as earlier experience as an Analyst at Soros Fund Management and OrbiMed. Andrew earned a BS in Finance and Statistics from NYU Stern School of Business and completed the Executive Education program at Harvard Business School in 2022.
This person is not in any teams
This person is not in any offices
Exome Asset Management
Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare.